Ferroptosis inhibitors—diarylamine para-acetamides
AssigneeSironax Ltd.
InventorsJianguang Han, Zhiyuan Zhang
Life of this patent
Estimating the term…
Abstract
Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
Claims20
A compound of formula I, or a pharmaceutically acceptable salt, hydrate or stereoisomer thereof:
- wherein:
- R1 is NR′R″, wherein R′ and R″ are independently selected from substituted or unsubstituted C1-C9 alkyl, and substituted or unsubstituted C5-C12 aryl, or wherein R′ and R″ are linked to form a substituted or unsubstituted 4- to 9-membered heterocycle containing 1 to 4 heteroatoms selected from N, O, and S;
- R2-R9 are independently H, halogen, C1-C6 alkoxy, amino, C1-C6 alkylamino, di-(C1-C6 alkyl)amino, or substituted or unsubstituted C1-C6 alkyl;
- R10 is H, halogen, C1-C6 alkoxy, amino, C1-C6 alkylamino, di-(C1-C6 alkyl)amino, or unsubstituted C1-C6 alkyl;
- R11 is H, OH, or substituted or unsubstituted C1-C4 alkyl;
- R12 is C1-C6 alkoxy, amino, C1-C6 alkylamino, di-(C1-C6 alkyl)amino, C1-C6 alkanoyl, carbamoyl, carboxyl, amido, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C3-C9 cycloalkyl, or substituted or unsubstituted 3- to 9-membered heterocycloalkyl containing 1 to 3 heteroatoms selected from N, O, and S;
- R11 and R12 are optionally joined to form a substituted or unsubstituted 3- to 18-membered heterocycle containing 1 to 4 heteroatoms selected from N, O, and S;
- and
- X1-X5 and Y1-Y5 are C;
- wherein the substituents are in a number ranging from 0 to 3, each independently selected from halogen, —R′, —OR′, ═O, ═NR′, ═N—OR′, —NR′R″, —SR′, —SiR′R″R″′, —OC(O)R′, —C(O)R′, —CO2R′, —CONR′R″, —OC(O)NR′R″, —NR″C(O)R′, —NR′—C(O)NR″R″′, —NR′—SO2NR″′, —NR″CO2R′, —NH—C(NH2)═NH, —NR′C(NH2)=NH, —NH—C(NH2)=NR′, —S(O)R′, —SO2R′, —SO2NR′R″, —NR″SO2R, —CN, —NO2, —N3, —CH(Ph)2, perfluoro(C1-C4)alkoxy, and perfluoro(C1-C4)alkyl;
- wherein R′, R″ and R″′ each independently refer to hydrogen, unsubstituted (C1-C8)alkyl, (C1-C8)alkyl substituted with one to three halogens, unsubstituted C6-C14 aryl, C6-C14 aryl substituted with one to three halogens, unsubstituted C1-C6 alkyl, C1-C6 alkoxy, C1-C6 thioalkoxy groups, or C6-C14 aryl-(C1-C4)alkyl groups, wherein when R′ and R″ are attached to the same nitrogen atom, they are optionally combined with the nitrogen atom to form a 5-, 6- or 7-membered ring.
Dependencies are inferred from the claim text.